Cardiotrophin-2 (Ctf2), a member of the cytokine family, plays a pivotal role in cellular processes, especially those related to the growth and development of cardiac tissues. Its primary function is to facilitate communication between cells, orchestrating a complex network of signals that govern cell proliferation, differentiation, and survival. The protein is encoded by the Ctf2 gene, which is regulated by a multitude of factors within the cellular environment. The expression of Ctf2 can be particularly responsive to changes in the cellular milieu, where it responds to various intracellular and extracellular stimuli. Understanding the regulation of Ctf2 is crucial for comprehending how cells adapt to different physiological conditions, especially those that demand enhanced cellular growth and regeneration. As a signaling molecule, Ctf2 is central to the maintenance of heart tissue, but it also has the potential to be responsive in other tissues where its expression might support cellular resilience and adaptability.
The expression of Ctf2 can be induced by a diverse array of chemical compounds, each interacting with unique cellular pathways. Forskolin, for instance, can raise intracellular cAMP levels, which in turn activates protein kinase A (PKA) and could lead to the induction of Ctf2 expression through the enhancement of transcriptional activity. Similarly, compounds like retinoic acid can act upon nuclear receptors, triggering gene expression cascades that include the upregulation of Ctf2, reflecting its role in cell differentiation and growth. On the other hand, histone deacetylase inhibitors such as Trichostatin A could promote a more accessible chromatin state, potentially facilitating the transcription of genes like Ctf2. Lithium chloride, known for its role in modulating Wnt/beta-catenin signaling pathways, might also contribute to an increase in Ctf2 expression, highlighting the complex interplay between signal transduction and gene expression. Moreover, agents that alter the DNA methylation status, such as 5-Azacytidine, could lead to the activation of genes involved in cardiac tissue repair and regeneration, including Ctf2. Each of these compounds engages with specific intracellular mechanisms, and through these interactions, the expression of Ctf2 could be significantly influenced, highlighting the intricate relationship between chemical signals and gene expression in the cellular landscape.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone could upregulate Ctf2 expression by attenuating inflammation, potentially triggering a compensatory increase in tissue repair proteins. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid may stimulate Ctf2 transcription by activating retinoic acid receptors, leading to the growth and differentiation of cardiac cells. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin is known to raise cAMP levels, which could lead to the activation of CREB and upregulation of genes like Ctf2 involved in cell survival. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA could induce Ctf2 by mimicking diacylglycerol, activating PKC, and initiating transcriptional events that promote cardioprotective gene expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can stimulate Wnt/beta-catenin signaling pathways, potentially leading to an increase in Ctf2 expression involved in cell proliferation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may induce Ctf2 by causing hypomethylation of DNA, which can lead to the activation of previously silenced genes in cardiac tissue. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, by inhibiting histone deacetylases, could lead to a more open chromatin structure and stimulate the transcription of Ctf2. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
Rosiglitazone can upregulate Ctf2 by acting as a PPAR-gamma agonist, enhancing the expression of genes involved in energy balance and lipid metabolism. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB 431542 may increase Ctf2 expression by inhibiting TGF-beta receptor activity, which can lead to altered signaling in cardiac repair processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin could inhibit mTOR signaling, leading to an upsurge in autophagy and potentially promoting the expression of survival genes like Ctf2. |